INAFM2

Across TCGA pan-cancer cohorts, INAFM2 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated INAFM2 data layer compared with 24 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher INAFM2 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated INAFM2 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC and CCRCC are the cancer types where INAFM2 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	III,IV	1.000	0.319	.023	8	view →
CCRCC	DFS	Quartile	All	0.379	0.831	.042	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

INAFM2–UCEC (OS)

Open the UCEC breakdown →